Sumitomo Mitsui Trust Group Inc. Sells 3,326 Shares of Healthpeak Properties, Inc. $DOC

Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 0.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,455,811 shares of the real estate investment trust’s stock after selling 3,326 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.35% of Healthpeak Properties worth $43,001,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brooklyn Investment Group boosted its stake in shares of Healthpeak Properties by 198.9% during the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 873 shares during the period. TCTC Holdings LLC boosted its stake in shares of Healthpeak Properties by 124.3% during the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 751 shares during the period. Dagco Inc. bought a new stake in Healthpeak Properties in the 1st quarter valued at $30,000. GKV Capital Management Co. Inc. bought a new stake in Healthpeak Properties in the 1st quarter valued at $36,000. Finally, Larson Financial Group LLC boosted its stake in Healthpeak Properties by 120.6% in the 1st quarter. Larson Financial Group LLC now owns 1,873 shares of the real estate investment trust’s stock valued at $38,000 after purchasing an additional 1,024 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Insider Activity at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 2,930 shares of the stock in a transaction dated Thursday, July 31st. The stock was bought at an average price of $17.06 per share, with a total value of $49,985.80. Following the acquisition, the chief executive officer owned 210,416 shares of the company’s stock, valued at approximately $3,589,696.96. This represents a 1.41% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Over the last ninety days, insiders acquired 5,910 shares of company stock worth $100,139. 0.23% of the stock is currently owned by insiders.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $19.06 on Tuesday. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.28 and a current ratio of 1.22. Healthpeak Properties, Inc. has a 52 week low of $16.63 and a 52 week high of $23.05. The stock has a market capitalization of $13.24 billion, a P/E ratio of -381.08, a price-to-earnings-growth ratio of 3.20 and a beta of 1.09. The stock has a fifty day moving average of $18.36 and a 200-day moving average of $17.91.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Healthpeak Properties had a negative return on equity of 0.44% and a negative net margin of 1.36%.The company had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same quarter in the previous year, the firm earned $0.45 EPS. Healthpeak Properties’s revenue was up .8% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be issued a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) dividend on an annualized basis and a dividend yield of 6.4%. Healthpeak Properties’s payout ratio is -2,440.00%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on DOC. Wall Street Zen downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Monday, July 7th. Weiss Ratings restated a “hold (c-)” rating on shares of Healthpeak Properties in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a research note on Monday, September 15th. Finally, Wells Fargo & Company reduced their price target on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 27th. Eight investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $21.33.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.